Celltrion Inc. et al. v. Genentech, Inc. et al. > Summary
Court Case Number IPR2017-01229
Filing Date Mar 31, 2017
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesSheridan K. Snedden, Erica A. Franklin, Jacqueline T. Harlow
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9
Petitioner
Patent Owner
Petitioner Attorneys
7Celltrion
Attorney Name: Alla Brukman
Cooley LLP
Celltrion
Attorney Name: Susan Krumplitsch
Cooley LLP
Celltrion
Attorney Name: Adam Pivovar
Cooley LLP
Celltrion
Attorney Name: James P. Brogan
Cooley LLP
Celltrion
Attorney Name: Michelle S. Rhyu
Cooley LLP
Celltrion
Attorney Name: Lauren J. Strosnick
Cooley LLP
Celltrion
Attorney Name: Michael Andreeff
The University of Texas M.D. Anderson Cancer Center
Patent Owner Attorneys
7Genentech, Inc
Attorney Name: Lauren N. Drake
Irell & Manella LLP
Genentech, Inc
Attorney Name: David I. Gindler
Irell & Manella LLP
Genentech, Inc
Attorney Name: Yite J. Lu
Irell & Manella LLP
Genentech, Inc
Attorney Name: Keith A. Orso
Irell & Manella LLP
Genentech, Inc
Attorney Name: Gary N. Frischling
Irell & Manella LLP
Genentech, Inc
Attorney Name: Michael R. Fleming
Irell & Manella LLP
Genentech, Inc
Attorney Name: David P. Schenkein
Genentech, Inc
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08206711 | Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies | Jun 26, 2012 |
